GM Medical A/S, a Danish-owned company, is pleased to announce its recent acquisition by Simonsen & Weel (S&W) – Diploma PLC company. This significant development, which was advised by Translink Corporate Finance in Denmark, has led to GM Medical’s inclusion within the esteemed Diploma Healthcare Group, operating within the Life Sciences sector.

According to Cindy Nijs, CEO and Director of Simonsen & Weel, GM Medical serves as a valuable addition to their growing portfolio of specialised products, reinforcing their focus on emerging segments. The acquisition notably bolsters their presence in Norway, Sweden, and Finland, enhancing their regional footprint.

Established in 1987, GM Medical A/S has been a prominent name in the market, specialising in medical equipment and consumables across various domains such as Surgery/Sterile Centres, Diagnostics, Anaesthesia/Intensive, Prehospital, Simulation, Neonatology/Paediatrics, Obstetrics, and Ultrasound. The company maintains subsidiaries in Sweden, Norway, and Finland.

Jesper Fremming, CEO of GM Medical, expressed enthusiasm for the partnership with Simonsen & Weel, highlighting their shared understanding and appreciation for GM Medical’s mission. The acquisition ensures that GM Medical retains local autonomy, flexibility, and responsiveness while gaining the necessary resources to fuel continued expansion.

Despite this new phase, GM Medical will continue to operate independently, preserving its current brand and commercial strategy with the dedication of its talented team of employees. Plans are underway to integrate commercial activities within the next year, bringing GM Medical fully under the S&W banner, as stated by Cindy Nijs, CEO and Director of S&W.